TCM
ACHV icon

Tekla Capital Management’s Achieve Life Sciences ACHV Stock Holding History

Tekla Capital Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-51
Closed -$264K – 161
2015
Q2 		$264K Hold
51
– – 0.01% 115
2015
Q1 		$243K Hold
51
– – 0.01% 116
2014
Q4 		$259K Hold
51
– – 0.01% 90
2014
Q3 		$302K Hold
51
– – 0.01% 107
2014
Q2 		$422K Hold
51
– – 0.04% 63
2014
Q1 		$1.33M Hold
51
– – 0.13% 57
2013
Q4 		$943K Hold
51
– – 0.1% 56
2013
Q3 		$1.05M Hold
51
– – 0.12% 59
2013
Q2 		$1.11M Buy
+51
New +$1.14M 0.15% 54

Other funds holding ACHV

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Tekla Capital Management's ACHV Position: Q3 2015 in Review

Tekla Capital Management sold out of Achieve Life Sciences (ACHV) in Q3 2015, closing a stake of 51 shares — an estimated $264K sold.

Tekla Capital Management first reported a position in ACHV in Q2 2013 and held it in 9 quarters. The position peaked at $1.33M in Q1 2014. 45 funds tracked by Wall St. Rank hold ACHV as of Q3 2015.

  • Tekla Capital Management reported no remaining Achieve Life Sciences position as of Q3 2015 after selling out during the quarter.
  • Tekla Capital Management sold 51 Achieve Life Sciences shares in Q3 2015, an estimated $264K.
  • Tekla Capital Management first reported a position in Achieve Life Sciences in Q2 2013 and held it in 9 quarters.
  • Tekla Capital Management's Achieve Life Sciences position peaked at $1.33M in Q1 2014.
  • 45 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2015.

Based on Tekla Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.